New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
H3K27M-mutant diffuse midline gliomas (DMGs) are rare childhood central nervous system tumors that carry a dismal prognosis. Thus, innovative treatment approaches are greatly needed to improve clinical outcomes for these patients. Here, we discuss current trends in research of H3K27M-mutant diffuse...
Guardado en:
Autores principales: | Davis P. Argersinger, Sarah R. Rivas, Ashish H. Shah, Sadhana Jackson, John D. Heiss |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9777d6178d8452eb0ff36817324d0b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
por: Cheng Xu, et al.
Publicado: (2021) -
Bioinformatics analysis of microarray data to reveal the pathogenesis of diffuse intrinsic pontine glioma
por: Wei,Li, et al.
Publicado: (2018) -
Rotating Magnetic Fields Inhibit Mitochondrial Respiration, Promote Oxidative Stress and Produce Loss of Mitochondrial Integrity in Cancer Cells
por: Martyn A. Sharpe, et al.
Publicado: (2021) -
H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines
por: Andria Rakotomalala, et al.
Publicado: (2021) -
Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning
por: Shulun Nie, et al.
Publicado: (2021)